Depression is one of the most common and prominent mental disorders in the world[1, 2]. At present, the incidence rate of depression is increasing year by year, which has become a research hot spot. In the research process, a reasonable animal model of depression is the key, mainly including environmental stress model, social stimulation model, surgical preparation model, Genetically modified animal model and postpartum depression model [20].Chronic Unpredictable Mild Stress (CUMS) is one of the classic methods for establishing depression models. Through long-term relatively mild and unpredictable human stimuli, animals exhibit depressive like behavior, and its etiology and pathological mechanism are similar to human depression. It has been widely accepted and applied in the establishment of depression animal models [21, 22].Depression like behavior can be detected through behavioral experiments such as sucrose preference test (SPT), open field test (OFT), and forced swimming test (FST) [23,24]. The prefrontal cortex is one of the brain regions that cause mood disorders, and its functional changes play an important role in the pathogenesis of depression[21].
In our present study, we found that lithium carbonate treatment for 4 weeks alleviated depression-like behaviors via decreased the protein levels of nerve cells p-JNK/JNK, P-C-Jun/C-Jun,caspase-3 and Bax and increased Bcl-2 level significantly in the prefrontal cortex of CUMS mice. This means that in addition to the role of lithium in regulating other neurotransmitters, regulating autophagy and JNK/C-Jun signaling pathways may be another mode of action of lithium.This result is similar to LiCl could down-regulate the apoptosis-related genes Caspase-3 and Bax, up-regulate Bcl-2, and down-regulate the inflammatory-related genes (NF-κB, NLRP3, TNF-α, and IL-1β) via inhibiting virus replication[16].Bc1-2 is widely regarded as a major neuroprotective protein, and genetic strategies that increase bc1-2 levels have demonstrated not only robust protection of neurons against diverse insults, but have also demonstrated an increase in the regeneration of mammalian CNS axons[25].
Lithium carbonate is a classic emotional stabilizer. For a long time, lithium has been one of the main drugs for treating bipolar disorder. However, there is not yet a good understanding of the etiology or drug treatment mechanisms of this disease[26].In addition to its current use in patients with bipolar disorder, lithium can also be used to treat acute brain injury, such as stroke and chronic progressive neurodegenerative diseases.Chuang [27] found that lithium in primary neurons can induce cell proliferation near the injury site, accompanied by the loss of proliferating cells in the subventricular area, and some of these proliferating cells show the phenotype of neurons or astrocyte.Tushar Dwivedi et al. confirmed the mechanism of lithium mediated BDNF protection in rat hippocampal neurons [28]. The loss of proximal prefrontal cortex volume in bipolar disorder patients receiving lithium carbonate therapy was suppressed [29].Since the neuroprotective effect of lithium may be related to clinical improvement, Lithium carbonate is closely related to its neuroprotective effect and improvement of depressive symptoms, which is worth studying.
In this experiment, mice were found to experience of anhedonia after being modeled by CUMS, characterized by a significant decrease in the sugar preference index of the model mice; In open field experiments, there is a decrease in autonomous activity, shorter movement distance, and a decrease in the number of grid crossings; In the forced swimming experiment, the time of immobility was prolonged. But these indexes all increased after the treatment with Lithium carbonate, which indicated that Lithium carbonate could improve the depressive symptoms of depressed mice.
At the molecular level, JNK signaling pathway is a member of the Mitogen activated protein kinase (MAPK) family, and can participate in cell proliferation, differentiation, apoptosis, intracellular and extracellular signal transduction and other processes [30].The activation of JNK is common in various neurodegenerative diseases, and recent studies have gradually confirmed the important role of JNK activation in the regulation of depressive behavior [31].YU et al. showed that Curcumin can inhibit cell apoptosis by inhibiting JNK/c-Jun signaling pathway, down regulating caspase-3 protein expression[32] .In recent years, its use in antidepressant treatment has been carried out in clinic or experiment. Evidence-based medicine has more evidence to confirm the antidepressant effect of Curcumin with great effect size[33],which has been considered as a potential antidepressant[34].In many studies, curcumin has shown efficacy in regulating neurotransmitter concentration, inflammatory pathways, excitotoxicity, neural plasticity, hypothalamic pituitary adrenal disorders, insulin resistance, oxidative and nitrous stress, and endogenous cannabinoid systems, all of which can participate in the pathophysiology of MDD[35]. One of more anti-depession mechanism is the activation of JNK.
This study show that lithium carbonate has potential points of action on the JNK/c-Jun pathway. Compared with the control group, the expression levels of apoptotic protein Bax and caspase-3 in the model group were significantly increased, and the level of anti apoptotic protein Bcl-2 was decreased, which all reversed after treatment with Lithium carbonate. The levels of apoptotic protein Bax and caspase-3 were decreased, and the level of anti-apoptotic protein Bcl-2 was increased by lithium carbonate.These results indicate that the antidepressant mechanism of Lithium carbonate is partly through inhibiting JNK/c-Jun, reducing the expression of pro apoptotic protein Bax and Caspase-3, and increasing the level of anti apoptotic protein Bcl-2 that produce reducing neuronal apoptosis.In fact, the effect of Lithium carbonate on depressive symptoms is also reliable in clinical practice[36].
This study also has the following aspects of insufficient. Firstly,as an antidepressant effect study of drugs, a control group of antidepressants should be set up. Unfortunately, this control group was not set up.Secondly,as an antidepressant effect study of mood stabilizer, a control group of a mood stabilizer should be set up. Unfortunately, this control group was also not set up.Thirdly,to study the therapeutic effects of drugs, it is necessary to investigate the differences in effects under different doses. Unfortunately, such a research design has not be designed. Because study found that role of low (0.2 mmol/kg) and high dose (2 mmol/kg) lithium and revealed that high dose lithium group was the most mobile so the least depressed in the tail suspension test[37].